Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/2009
01/15/2009WO2009008466A1 Phosphatidate phosphatase homolog and use of the same
01/15/2009WO2009008414A1 Monoclonal antibody having neutralizing activity against mmp13
01/15/2009WO2009007982A1 A conserved region of the hiv-1 genome and uses thereof
01/15/2009WO2009007979A2 Encapsulated mesenchymal stem cells and uses thereof
01/15/2009WO2009007852A2 Multipotent/pluripotent cells and methods
01/15/2009WO2009007618A2 Tumour-cell-fixing cells
01/15/2009WO2009007503A1 Delivery of nucleic acids into genomes of human stem cells using in vitro assembled mu transposition complexes
01/15/2009WO2009007120A2 Tnf superfamily collectin fusion proteins
01/15/2009WO2009006997A1 Human pluripotent stem cells and their medical use
01/15/2009WO2009006930A1 Human pluripotent stem cells induced from undifferentiated stem cells derived from a human postnatal tissue
01/15/2009WO2009006782A1 CLONING TRANSCRIPTION FACTOR GENE OsWOX20 THAT REGULATES THE GROWTH AND DEVELOPMENT OF MONOCOTYLEDON'S ROOT AND USES THEREOF
01/15/2009WO2009006751A1 Neurons and methods for preparing them
01/15/2009WO2008148105A8 Endometrial stem cells and methods of making and using same
01/15/2009WO2008144580A3 Primate stem cells produced by somatic cell nuclear transfer
01/15/2009WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof
01/15/2009WO2008124166A3 Fusion proteins of collagen-binding domain and parathyroid hormone
01/15/2009WO2008110578A3 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts
01/15/2009WO2008098942A3 Process and support structure for the cultivation of living cells
01/15/2009WO2008097854A4 Method and substances for treating hpv infection
01/15/2009WO2008017598A3 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon
01/15/2009WO2007117602A3 Isolation and use of human regulatory t cells
01/15/2009US20090019608 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
01/15/2009US20090019607 Transgenic plant cells expressing a transcription factor
01/15/2009US20090019604 Soybean variety d4203144
01/15/2009US20090019603 Soybean variety d4696658
01/15/2009US20090019595 Soybean variety d4102367
01/15/2009US20090019594 Soybean variety d4266582
01/15/2009US20090019593 Soybean variety d4422801
01/15/2009US20090019592 Soybean variety d4356652
01/15/2009US20090019591 Soybean variety d4456885
01/15/2009US20090019590 Soybean variety d4698013
01/15/2009US20090019589 Soybean variety d4637114
01/15/2009US20090019588 Soybean variety d4520980
01/15/2009US20090019587 Soybean variety d4521369
01/15/2009US20090019586 Soybean variety d4223057
01/15/2009US20090019585 Soybean variety d4682156
01/15/2009US20090019584 Soybean variety d4233569
01/15/2009US20090019583 Soybean variety d4925614
01/15/2009US20090019582 Soybean variety d4102536
01/15/2009US20090019578 Soybean variety d4258962
01/15/2009US20090019577 Soybean variety d4253969
01/15/2009US20090019576 Soybean variety d4256925
01/15/2009US20090019575 Soybean variety d4253681
01/15/2009US20090019574 Soybean variety d4789254
01/15/2009US20090019573 Soybean variety d4713125
01/15/2009US20090019570 Soybean variety d4012368
01/15/2009US20090019561 Pepper Hybrid E 499531
01/15/2009US20090019560 Removing ovocyte and placing in proteasome inhibitor solution to prevent activation, transferring nucleus of donor cell, activating and implanting into uterus of recipient; producing animal models
01/15/2009US20090019558 Pgds as modifiers of the pten pathway and methods of use
01/15/2009US20090019554 Targeted cell death
01/15/2009US20090018868 Method for Utilizing Cell Therapy Product Facility and Network-Based Business Model Using the Same
01/15/2009US20090018218 METHODS OF MODIFYING AMYLOID beta OLIGOMERS USING NON-PEPTIDIC COMPOUNDS
01/15/2009US20090018099 Protein production
01/15/2009US20090018097 Modification of double-stranded ribonucleic acid molecules
01/15/2009US20090018096 Methods For Regulating The Growth And/Or Survival Of Tumor Cells And Stem Cells By Modulating The Expression Or Function Of The Transcription Factor ATF5
01/15/2009US20090018088 Treating cancer with cardiac glycosides
01/15/2009US20090018077 Fibroblast Growth Factor-Like Polypeptides
01/15/2009US20090018076 Fibroblast Growth Factor-Like Polypeptides
01/15/2009US20090018071 Epididymis-specific receptor protein
01/15/2009US20090018070 Fsh Mutants
01/15/2009US20090018068 G-protein coupled receptors
01/15/2009US20090018067 Regulatory t cell epitopes, compositions and uses thereof
01/15/2009US20090018063 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
01/15/2009US20090018059 Method for maintaining pluripotency of stem/progenitor cells
01/15/2009US20090018033 Cell Aggregation and Encapsulation Device and Method
01/15/2009US20090018016 Bacterial glutamine synthetases and methods of use
01/15/2009US20090017557 FVII Specific Antibodies and Use Thereof
01/15/2009US20090017542 producing high titer, wild-type-free preparations of recombinant AAV (adeno-associated virus) virions; for use as tools in genetic engineering and gene therapy
01/15/2009US20090017541 Porous Sheet-Form Material For Cell Culture, And Bioreactor And Culturing Method Utilizing Same
01/15/2009US20090017540 Method of culturing cells under regulation in the extension direction
01/15/2009US20090017539 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics
01/15/2009US20090017538 For modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein
01/15/2009US20090017537 hT2R54 Receptor Polypeptides and Nucleic Acid Sequences
01/15/2009US20090017536 Modified vaccinia ankara virus variant and cultivation method
01/15/2009US20090017535 Biomarkers; fusion proteins
01/15/2009US20090017534 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders
01/15/2009US20090017533 Optimized messenger rna
01/15/2009US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction
01/15/2009US20090017508 Streptomyces Avermitilis Gene Directing The Ratio of B2:B1 Avermectins
01/15/2009US20090017498 Fibroblast Growth Factor-Like Polypeptides
01/15/2009US20090017494 Tick octopamine receptor nucleic acid molecules, proteins and uses thereof
01/15/2009US20090017492 SVPH1-26 DNA and polypeptides
01/15/2009US20090017490 DNA Fragment Method for Producing Transformant for Protein Production and Utilization Thereof
01/15/2009US20090017489 Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof
01/15/2009US20090017465 Compound Screening Using Cardiomyocytes
01/15/2009US20090017460 Differential expression profiling analysis of cell culture phenotypes and uses thereof
01/15/2009US20090017440 Increasing the viability and stress tolerance of viable biological material
01/15/2009US20090017439 Compositions and methods for enhancing the viability of animal cells, tissues, and organ explants
01/15/2009US20090017438 Methods and compositions for the preservation of cells and tissues
01/15/2009US20090017437 Fixative composition
01/15/2009US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions
01/15/2009US20090017092 Novel Class of Cell-Interactive Material and Process of Preparation of Artificial Tissues of Human and Animal Origin
01/15/2009US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis
01/15/2009US20090017070 In vitro model for hepatitis c virion production
01/15/2009US20090017068 Vaccines against West Nile Virus
01/15/2009US20090017065 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
01/15/2009US20090017054 nucleic acids corresponding to entire coding sequences of S. pneumoniae proteins, including surface or secreted proteins or parts thereof; for diagnostics, prophylaxis and treatment of bacterial infection; vaccines
01/15/2009US20090017049 BetaGBP, compositions comprising betaGBP, and related methods and uses thereof
01/15/2009US20090017048 Novel Brachyspira hyodysenteriae vaccine
01/15/2009US20090017044 Antibodies to the Human Prolactin Receptor